Navigation Links
Cumberland Pharmaceuticals Reports Third Quarter 2011 Financial Results
Date:11/3/2011

productlicense right

171,727171,732515,180515,184Other

31,68027,86980,73583,283Total costs and expenses

9,955,9189,747,01329,972,72828,797,232Operating income

3,098,3602,443,8578,138,2184,264,225Interest income

52,45948,675147,628159,688Interest expense

(33,390)(547,795)(329,037)(1,299,703)Income before income taxes

3,117,4291,944,7377,956,8093,124,210Income tax expense

(1,278,472)(943,141)(3,238,421)(1,529,339)Net income

1,838,9571,001,5964,718,3881,594,871Net loss at subsidiary attributable tononcontrolling interests

8,4556,64827,80324,255Net income attributable tocommon shareholders

$
,847,412$
,008,244$
4,746,191$
,619,126Earnings per share attributable to common shareholders- basic

$
.09$
.05$
.23$
.08- diluted

$
.09$
.05$
.23$
.08Weighted-average shares outstanding- basic

20,327,53720,327,86720,414,59320,335,911- diluted

20,534,64720,803,18220,657,56721,135,762CUMBERLAND PHARMACEUTICALS INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows
(Unaudited)Nine Months Ended September 30,20112010Cash flows from operating activities:Net income

$
4,718,388$
,594,871Adjustments to reconcile net income to net cash flows fromoperating activities:Depreciation and amortization expense

801,483723,687Non-employee equity compensation

119,31362,547Stock-based compensation - employee stock options

467,850503,446Excess tax benefit derived from exercise of stock options

(2,657,259)(1,256,913)Non-cash interest expense

131,469328,475Net changes in assets and liabilities affectingoperating activities:Accounts receivable

640,0831,384,903Inventory

809,243(2,823,355)Other current assets and other assets

(1,240,700)1,461,538Accounts payable and other accrued liabilities

3,911,450(840,429)Other long-term obligations

(9,262)(105,668)
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Cumberland Pharmaceuticals Taps Industry Veteran for Key Executive Position
2. Neurotech Announces the Opening of Its GMP Manufacturing Facility in Cumberland, Rhode Island
3. Cumberland Pharmaceuticals Appoints Lee Product Director
4. Cumberland Emerging Technologies and UT Research Foundation Sign License Agreement for New Technology
5. Cumberland Pharmaceuticals Provides Hospital In-Service Webcast for Acetadote(R)
6. Cumberland Pharmaceuticals Announces FDA Approval of Caldolor(TM)
7. Cumberland Pharmaceuticals Announces Pricing of Its Initial Public Offering of Common Stock
8. Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
9. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
10. ISTA Pharmaceuticals Reports Second Quarter 2008 Financial Results
11. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Psyche Systems Corporation and Luminate Health ... first-of-its-kind platform that helps labs comply with new federal ... the way patients engage with these results, and improves ... provides a HIPAA-compliant digital platform that gives labs an ... their lab results, and uniquely connects labs, physicians, and ...
(Date:5/5/2015)...  Renova™ Therapeutics, a biopharmaceutical company developing gene ... chronic diseases, has engaged RAND Health Advisory Services ... the healthcare patterns of multiple advanced heart failure ... to characterize the impact the company,s lead product, ... of patients and the overall health care system. ...
(Date:5/5/2015)... 2015  A group of biotechnology executives and medical ... Institute, a non-profit organization dedicated to providing education, research ... disorders of consciousness.  ... Coma ... no voluntary actions can be initiated by the patient, ...
(Date:5/5/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Clinical Laboratory, ... and Forecast 2015 to 2019 - Global Version" ... technical developments especially in the area of molecular ... dynamic, growing and evolving world market that is ...
Breaking Biology Technology:Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 2Psyche Systems Corporation Forms Strategic Alliance with Luminate Health to Provide First-of-its-kind Patient Access Solution 3RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 2Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 3Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 4Biotechnology Executives and Medical Doctors Team Up to Tackle Coma and Disorders of Consciousness 5Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... 3 .decimal, Inc. announced today that,it has ... to supply,patient-specific devices for its proton therapy facility ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090203/CLTU104LOGO ) , ... a formal agreement signed with ProCure to be,their ...
... Sleep Apnea TreatmentSAN CARLOS, Calif., Feb. 3 ... shown their patients comply with Obstructive Sleep Apnea ... average.Analysis performed in October 2008 looked at Northern ... treatment with Positive Airway Pressure beginning in early ...
... Feb. 3 BioMarin Pharmaceutical Inc. (Nasdaq: ... Surveillance Agency, has granted BioMarin marketing approval for Naglazyme(R) ... (MPS VI)."We are very pleased to receive marketing approval ... number of affected MPS VI patients in the world," ...
Cached Biology Technology:ProCure Signs Agreement with .decimal, Inc. to Purchase Patient-Specific Devices for Its Proton Therapy Center in Oklahoma City 2SleepQuest Compliance Again Doubles Industry Average 2Naglazyme Approved by Brazil's National Health Surveillance Agency 2Naglazyme Approved by Brazil's National Health Surveillance Agency 3Naglazyme Approved by Brazil's National Health Surveillance Agency 4
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
(Date:4/6/2015)... 6, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND ... NXT-ID introduces a new revolutionary method and ... the use of miniature antenna modules for multiple ...
(Date:4/2/2015)... , April 2, 2015 ... Q1 2015 attributed to somewhat higher than 125 MSEK. ... the year-end report 2014 that revenues for Q1 2015 ... the company reported for Q4 2014. The operating result ... be negative. The complete interim report will as previously ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... Foundation (NSF) announced that it will serve as the ... US Ignite, which aims to realize the potential of ... on investments in the NSF-funded Global Environment for Networking ... this initiative. "NSF is proud to be the ...
... wide range of diseases and uncover fundamental processes that lead ... for biomedical science. A number of hurdles, both scientific and ... of using these special cells to treat heart disease, diabetes, ... June 13 in Nature , scientists at the Salk ...
... of California, San Diego Jacobs School of Engineering ... to self-assemble into larger, complex materials for next-generation ... and, like bricks or Tetris blocks, spontaneously organize ... to one another. Their findings were published ...
Cached Biology News:NSF Leadership in Discovery and Innovation sparks White House US Ignite Initiative 2NSF Leadership in Discovery and Innovation sparks White House US Ignite Initiative 3'Magical state' of embryonic stem cells may help overcome hurdles to therapeutics 2'Magical state' of embryonic stem cells may help overcome hurdles to therapeutics 3Self-assembling nanocubes for next generation antennas and lenses 2
Human PDGF R beta MAb (Clone # PR7212)...
Zebrafish Ephrin-B2 Biotinylated Affinity Purified PAb...
Collected from 8-12 week old New Zealand or Californian rabbits. Aseptically collected and processed to minimize hemolytic activity. Pricing: $60/unit for 1 - 10 units...
One-step, microplate or cuvet, colorimetric, detection range 0.3 g/dL to 5 g/dL. Procedure: 5 min....
Biology Products: